NCT06519110 2024-07-25CVL009-C2001Convalife (Shanghai) Co., Ltd.Phase 2 Not yet recruiting60 enrolled
NCT00266877 2018-04-13Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung CancerPuma Biotechnology, Inc.Phase 2 Completed172 enrolled 11 charts